| Literature DB >> 35479128 |
Maizatul Najwa Jajuli1,2, Grégoire Herzog2, Marc Hébrant2, Ng Eng Poh3, Afidah Abdul Rahim3, Bahruddin Saad4, M Hazwan Hussin3.
Abstract
A bar micro-solid phase (bar μ-SPE) extraction method using either graphene or zeolite or their mixtures as an adsorbent, coupled with high-performance liquid chromatography (using a C1 column) was developed for the simultaneous determination of pharmaceutical compounds (metformin (MET), buformin (BUF), phenformin (PHEN) and propranolol (PROP)) of diverse polarity (log P from -1.82 to 3.10). Parameters influencing the extraction, such as conditioning solvents, pH of the sample, sample volume, amount of adsorbent, stirring rate, time of extraction, type and volume of desorption solvent and time of desorption were investigated. Under the optimized conditions, the extraction method using graphene (extraction efficiency, % EE, ∼6-15%) resulted in the least amount of extracted drugs. However, the use of zeolite and zeolite/graphene mixtures improves the % EE significantly, i.e. 30% for PHEN and 42% for PROP using zeolite; 22% for MET and 18% for BUF using the adsorbent mixture. Under similar conditions, enrichment factors for these drugs range from 11-15. The validated method was performed for the determination of the drugs that were spiked to urine samples. Good recoveries ranging from 72.8 to 116% were achieved. This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 35479128 PMCID: PMC9031021 DOI: 10.1039/d1ra01569a
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Pertinent information on the pharmaceutical compounds studieda
| Compounds | Structure | Log | p |
|---|---|---|---|
| Metformin (MET) |
| −1.82a | 11.5b |
| Buformin (BUF) |
| −1.20c | 12.27c |
| Phenformin (PHEN) |
| 0.41a | 11.8e |
| Propranolol (PROP) |
| 3.10a | 9.49f |
a Calculated using Chemsketch from ACDlabs; b, d–f ref. 37–40; c SciFin.
Fig. 1Preparation of bar-μ-SPE. (a) Preparation of PP bag (b) insertion of metal rod in PP bag (c) heat-sealed of edges (d) completed device.
Fig. 2Effect of pH on the extraction of drugs. Experimental conditions: conditioning solvent, ACN; volume of extraction solvent, 20 mL; amount of adsorbent, 20 mg; time of extraction, 60 min; rotation speed, 800 rpm.
Fig. 3Effect of time of extraction on the extraction of drugs. Experimental conditions: conditioning solvent, ACN; volume of solution, 10 mL; pH solution, pH 10 (graphene) and pH 3 (zeolite); amount of adsorbent, 10 mg (graphene) and 25 mg (zeolite); rotating speed, 800 rpm.
Summary of the adopted conditions of bar-μ-SPE-HPLC method using graphene and zeolite as adsorbenta
| Conditions | Graphene | Zeolite | Zeolite : graphene |
|---|---|---|---|
| Conditioning solvent | ACN | ACN | ACN |
| pH of sample solution | 10 | 3 | 6 |
| Volume of sample solution, mL | 10 | 10 | 10 |
| Amount of adsorbent | 10 mg | 25 mg | 24.5 mg : 10.5 mg |
| Rotating speed, rpm | 800 | 800 | 800 |
| Time of extraction, min | 90 | 120 | 120 |
| Ionic strength, % NaCl | 0 | 0 | 0 |
| Solvent for desorption | 0.1 M IP in IPA | 0.1 M IP in ACN | 7 : 3 (ACN : IPA) + 0.1 M IP |
| Time of desorption, min | 30 | 30 | 30 |
| Volume of desorption solvent, mL | 0.6 | 0.6 | 0.6 |
IP: ion-pair (sodium heptanesulphonate).
Fig. 4Effect of different desorption solvent mixtures on peak area using mixed adsorbent. Experimental conditions: volume of desorption solvent, 0.60 mL; sonication time, 30 min.
Interday and intraday reproducibility (% RSD) as well as recovery for urine spiked sample (n = 6) using mixed-adsorbent
| Parameter, spiked level (μg L−1) | MET | BUF | PHEN | PROP |
|---|---|---|---|---|
|
| ||||
| 600 | 6.66 | 6.91 | 7.35 | 8.40 |
| 750 | 5.16 | 8.28 | 8.62 | 6.90 |
| 950 | 4.99 | 6.27 | 5.73 | 5.87 |
|
| ||||
| 600 | 8.28 | 8.62 | 8.55 | 9.12 |
| 750 | 8.02 | 8.87 | 9.01 | 7.80 |
| 950 | 6.50 | 7.23 | 7.41 | 7.67 |
|
| ||||
| 600 | 85.4 ± 8.98 | 84.6 ± 10.2 | 109 ± 8.15 | 97.0 ± 8.58 |
| 750 | 75.1 ± 6.92 | 72.8 ± 8.53 | 114 ± 13.5 | 116 ± 16.7 |
| 950 | 80.9 ± 4.57 | 81.2 ± 1.76 | 116 ± 8.95 | 97.8 ± 7.06 |
Fig. 5Typical chromatogram of urine sample that was spiked with 950 μg L−1 drugs and subjected to the bar-μ-SPE-HPLC method using mixed-adsorbent. Chromatographic conditions: column, Zorbax TMS (250 × 4.6 mm); mobile phase, 20 mM phosphate buffer (pH 6.2) : ACN : triethylamine (45 : 55 : 0.2, v/v); λ, 230 nm; flow rate, 1.3 mL min−1.
Fig. 6(a) EE % and (b) EF values for different types of adsorbents studied.
Comparison of previously reported methods for the simultaneous determination of analytesa
| Sample preparation and determination | Sample | Analytes | p | Log | LOD (μg L−1) | LOQ (μg L−1) | Recovery (%) | Ref. |
|---|---|---|---|---|---|---|---|---|
| IP SPE-IP LC | Plasma | MET | — | — | 3 | 5 | 97.9–100.5 |
|
| SPE-non-aqueous CE | Plasma | MET | 131 | — | 12 | — | — |
|
| PHEN | 12.7 | 6 | — | — | ||||
| IP SPE-HPLC MS | Plasma | MET | — | −1.80 | — | 2.49 | 86.1 |
|
| Bar-μ-SPE-HPLC UV | Urine | MET | 11.5 | −1.82 | 4.03 | 12.2 | 75.1–85.4 | This work |
| BUF | 12.3 | −0.03 | 3.94 | 11.9 | 72.8–84.6 | |||
| PHEN | 11.8 | 0.41 | 6.90 | 20.9 | 109–116 | |||
| SPE-LC ESI/MS MS | Plasma | PROP | — | — | 0.05 | 0.20 | 96.4–98.5 |
|
| 4-HYD PROP | — | — | 0.10 | 0.20 | 64.7–66.2 | |||
| EME-GC MC | Wastewater | PROP | — | — | 0.0081 | — | 80.0 |
|
| NOR | — | — | 0.13 | — | 18.0 | |||
| IBU | — | — | 0.13 | — | 20.0 | |||
| ALP | — | — | 0.18 | — | 23.0 | |||
| NAP | — | — | 0.26 | — | 26.0 | |||
| KETO | 4.2–9.5 | — | 0.027 | — | 40.0 | |||
| MIP SBSE-HPLC UV | Urine | PROP | 9.50 | 2.90 | 0.37 | 1.0 | 86.8–106 |
|
| SPE-UHPLC UV | Urine | PROP | — | — | 19 | 59 | 85.5–105 |
|
| Bar-μ-SPE-HPLC UV | Urine | PROP | 9.49 | 3.10 | 17.0 | 51.6 | 97.0–116 | This work |
Abbreviations: MISPE: molecularly imprinted solid phase extraction, MIP: molecularly imprinted polymer, TFA: trifluoroacetic acid, IP SPE: ion pair solid phase extraction, IP LC: ion pair liquid chromatography, 4-HYD PROP: 4-hydroxy propranolol, EME: electromembrane extraction, NOR: norephedrine, IBU: ibuprofen, ALP: alprenolol, NAP: naproxen, KETO: ketoprofen, MIP SBSE: molecularly imprinted polymer stir-bar sorptive extraction, UHPLC: ultra high-performance liquid chromatography, ESI: electrospray ionization, MS: mass spectrometry.